Sign in
4

Changes in Ownership

Grace Therapeutics, Inc. Filed Acc 0001493152-26-048591

10% owner bought 87,801 shares at an average $1.81 ($158,601)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Opaleye Management Inc. 10% owner 2026-10-22 Purchase +21,390 $1.93 $41,193 2,970,000 I
Opaleye Management Inc. 10% owner 2026-10-26 Purchase +66,411 $1.77 $117,408 3,036,411 I
Open-market purchases · 87,801 sh · avg $1.81 · $158,601
Loading xslF345X06/ownership.xml…